神經可塑性市場分析及預測（至2035年）：依類型、產品類型、服務、技術、應用、最終使用者、設備、流程、解決方案分類

預計神經可塑性市場將從2024年的63億美元成長到2034年的632億美元，複合年成長率約為26%。神經可塑性市場涵蓋旨在增強大腦透過形成新的神經連接進行自我重組能力的治療方法和技術。該市場包括認知訓練項目、神經刺激設備以及針對神經系統疾病和認知衰退的藥物。人們對大腦可塑性的深入了解正在推動對創新解決方案的需求，以改善心理健康和神經康復，並促進個人化治療和腦機介面（BCI）技術的進步。

神經可塑性市場在神經科學進步和人們對大腦健康日益成長的關注推動下持續穩步擴張。認知訓練領域處於領先地位，數位化平台和應用程式能夠有效提升思維敏捷性和記憶力。這些工具正被擴大應用於教育和職場場所。製藥業也緊隨其後，用於改善認知功能的神經增強藥物和補充劑越來越受歡迎。經顱磁刺激等新興療法也備受關注，為人們提供了一種非侵入性的腦刺激選擇。復健領域也呈現顯著成長，尤其是在中風後復健和創傷性腦損傷治療方面。創新的復健技術正利用神經可塑性來改善患者的治療效果。同時，心理健康領域也不斷發展，正念和冥想練習正被納入治療方案。這種綜合辦法兼顧心理健康和認知功能，反映了腦部健康綜合解決方案的更廣泛趨勢。對研發投入的不斷增加正在推動市場的進一步發展。

神經可塑性市場正經歷動態變化，主要參與者之間市佔率分佈均衡。定價策略也在不斷演變，反映出市場對創新神經可塑性療法和干涉措施日益成長的需求。在神經科學研究和技術進步的推動下，新產品層出不窮。各公司正專注於個人化和標靶化治療方案，這在已開發市場和新興市場都引起了廣泛關注。神經可塑性市場的競爭異常激烈，主要參與者不斷相互對標，以保持競爭優勢。監管政策，尤其是在北美和歐洲，對市場動態的形成起著至關重要的作用。這些法規確保了基於神經可塑性產品的安全性和有效性，從而增強了消費者和相關人員的信任。此外，能夠提升產品性能和拓展治療應用的技術進步也在影響市場。這些因素的相互作用為神經可塑性領域的成長和創新帶來了巨大的機會。

主要趨勢和促進因素：

神經可塑性市場正經歷強勁成長，這主要得益於對大腦健康研究的不斷深入以及神經影像技術的進步。關鍵趨勢包括認知訓練項目的興起以及人工智慧在神經復健領域的應用。這些創新使得個人化治療性介入可能，並能改善神經系統疾病患者的復原效果。推動該市場發展的因素包括神經退化性疾病的日益普遍以及全球人口老化。這促使人們對利用大腦自我重塑能力的治療方法的需求不斷成長。此外，人們對心理健康問題的日益關注也推動了對神經可塑性研究和應用領域的投資。學術機構、醫療保健機構和科技公司之間的合作也促進了市場的發展。開發提供遠端認知訓練和監測的數位平台存在著許多機會。專注於方便用戶使用且擴充性解決方案的公司預計將佔據可觀的市場佔有率。透過創新的神經可塑性解決方案來改善生活品質的理念預計將推動市場持續擴張。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

• 宏觀經濟分析
• 市場趨勢
• 市場促進因素
• 市場機遇
• 市場限制
• 複合年均成長率：成長分析
• 影響分析
• 新興市場
• 技術藍圖
• 戰略框架

第4章 細分市場分析

• 市場規模及預測：依類型
  • 認知功能改善
  • 復原
  • 學習和記憶
  • 減輕壓力
  • 情緒調節
• 市場規模及預測：依產品分類
  • 神經刺激設備
  • 認知訓練軟體
  • 神經回饋系統
  • 腦監測設備
• 市場規模及預測：依服務分類
  • 諮詢服務
  • 培訓和研討會
  • 治療服務
  • 研究與開發
• 市場規模及預測：依技術分類
  • 經顱磁刺激（TMS）
  • 腦電圖（EEG）
  • 功能性磁振造影
  • 近紅外線光譜
• 市場規模及預測：依應用領域分類
  • 醫療保健與健康
  • 教學與學習
  • 運動與表現
  • 軍事和國防領域
  • 趣味遊戲
• 市場規模及預測：依最終用戶分類
  • 醫院和診所
  • 學術研究機構
  • 公司的
  • 體育組織
  • 軍事和國防機構
• 市場規模及預測：依設備分類
  • 穿戴式裝置
  • 非侵入式設備
  • 侵入性設備
  • 攜帶式裝置
  • 固定設備
• 市場規模及預測：依製程分類
  • 神經回饋
  • 腦刺激
  • 認知訓練
  • 正念與冥想
• 市場規模及預測：按解決方案分類
  • 個人化培訓解決方案
  • 綜合治療方案
  • 基於人工智慧的解決方案
  • 基於雲端的解決方案

第5章 區域分析

• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 其他拉丁美洲地區
• 亞太地區
  • 中國
  • 印度
  • 韓國
  • 日本
  • 澳洲
  • 台灣
  • 亞太其他地區
• 歐洲
  • 德國
  • 法國
  • 英國
  • 西班牙
  • 義大利
  • 其他歐洲地區
• 中東和非洲
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非
  • 撒哈拉以南非洲
  • 其他中東和非洲地區

第6章 市場策略

• 需求與供給差距分析
• 貿易和物流限制
• 價格、成本和利潤率趨勢
• 市場滲透率
• 消費者分析
• 法規概述

第7章 競爭訊息

• 市場定位
• 市場占有率
• 競爭基準
• 主要企業的策略

第8章：公司簡介

• Neuro Flow
• Cognifit
• Brain HQ
• Neuro Nation
• Lumosity
• Elevate
• Posit Science
• Mind Maze
• Brain Co
• Neurable
• Neuro Sky
• Emotiv
• Muse
• Insight Timer
• Brain.fm
• Focus@Will
• Happify
• Headspace Health
• Calm
• Synctuition

第9章：關於我們

Neuroplasticity Market is anticipated to expand from $6.3 billion in 2024 to $63.2 billion by 2034, growing at a CAGR of approximately 26%. The Neuroplasticity Market encompasses therapies and technologies aimed at enhancing the brain's ability to reorganize itself by forming new neural connections. This market includes cognitive training programs, neurostimulation devices, and pharmaceuticals targeting neurological disorders and cognitive decline. As understanding of brain plasticity grows, demand for innovative solutions to improve mental health and neurorehabilitation is increasing, driving advancements in personalized therapy and brain-computer interfaces.

The Neuroplasticity Market is experiencing robust expansion, driven by advancements in neuroscience and increasing awareness of brain health. The cognitive training segment is at the forefront, with digital platforms and applications enhancing mental agility and memory. These tools are increasingly adopted in educational and professional settings. The pharmaceuticals segment follows closely, with neuro-enhancing drugs and supplements gaining popularity for cognitive improvement. Emerging therapies, such as transcranial magnetic stimulation, are gaining traction, offering non-invasive brain stimulation options. The rehabilitation segment is also seeing significant growth, particularly in post-stroke recovery and traumatic brain injury treatments. Innovative rehabilitation methods are leveraging neuroplasticity to improve patient outcomes. Meanwhile, the mental health sub-segment is expanding, with mindfulness and meditation practices being integrated into therapeutic regimens. This holistic approach addresses mental well-being and cognitive function, reflecting a broader trend towards comprehensive brain health solutions. Growing investment in research and development further propels the market's evolution.

The Neuroplasticity Market is experiencing a dynamic shift, characterized by a robust market share distribution among key players. Pricing strategies are evolving, reflecting the increasing demand for innovative neuroplasticity therapies and interventions. New product launches are frequent, driven by advancements in neuroscientific research and technology. Companies are focusing on personalized and targeted treatment solutions, which are gaining traction in both developed and emerging markets. Competition in the Neuroplasticity Market is intense, with major players continuously benchmarking against each other to maintain a competitive edge. Regulatory influences, particularly in North America and Europe, are pivotal in shaping market dynamics. These regulations ensure the safety and efficacy of neuroplasticity-based products, fostering trust among consumers and stakeholders. The market is further influenced by technological advancements, which are enhancing product offerings and expanding therapeutic applications. The interplay of these factors presents lucrative opportunities for growth and innovation in the neuroplasticity sector.

Geographical Overview:

The neuroplasticity market is witnessing remarkable growth across various regions, each offering unique opportunities. North America leads the market, driven by substantial investments in neuroscience research and innovative therapeutic solutions. The region's advanced healthcare infrastructure and focus on mental health further bolster market expansion. Europe follows closely, with a strong emphasis on research and development in neuroplasticity therapies. The region's commitment to mental health initiatives and supportive regulatory frameworks enhance its market potential. In Asia Pacific, the market is expanding rapidly due to increased awareness and investments in neurological health. Countries such as China and India are emerging as key players, fueled by technological advancements and rising healthcare expenditures. Latin America and the Middle East & Africa are emerging markets with significant growth potential. In Latin America, increasing awareness of mental health issues is driving demand for neuroplasticity therapies, while the Middle East & Africa are recognizing the importance of neurological health in enhancing overall well-being.

The global neuroplasticity market, pivotal in cognitive enhancement and rehabilitation, is influenced by tariffs and geopolitical dynamics, particularly in Asia. Japan and South Korea, traditionally reliant on US and European neurotechnology, are investing in local innovation to mitigate tariff-induced cost pressures. China's strategic focus on self-sufficiency propels its investment in indigenous neuroplasticity research, while Taiwan leverages its semiconductor prowess to advance neurotech components, albeit under geopolitical strain. The parent market, encompassing cognitive health and neurorehabilitation, is experiencing robust growth globally, driven by aging populations and technological advancements. By 2035, the market is poised for significant expansion, contingent on cross-border collaborations and resilient supply chains. Middle East conflicts, while indirectly affecting the neuroplasticity market, may influence energy costs, impacting global manufacturing and distribution.

Key Trends and Drivers:

The neuroplasticity market is experiencing robust growth, driven by increasing research on brain health and advancements in neuroimaging technologies. Key trends include the rise of cognitive training programs and the integration of artificial intelligence in neurorehabilitation. These innovations are enabling personalized therapeutic interventions, enhancing recovery outcomes for patients with neurological disorders. Drivers of this market include the growing prevalence of neurodegenerative diseases and the aging global population. There is a heightened demand for non-invasive treatments that leverage the brain's ability to reorganize itself. Additionally, increased awareness of mental health issues is propelling investments in neuroplasticity research and applications. The market is also benefiting from collaborations between academia, healthcare providers, and technology firms. Opportunities abound in developing digital platforms that offer remote cognitive training and monitoring. Companies focusing on user-friendly, scalable solutions are well-positioned to capture significant market share. The emphasis on improving quality of life through innovative neuroplasticity solutions is expected to drive sustained market expansion.

Research Scope:

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

• 1.1 Market Size and Forecast
• 1.2 Market Overview
• 1.3 Market Snapshot
• 1.4 Regional Snapshot
• 1.5 Strategic Recommendations
• 1.6 Analyst Notes

2 Market Highlights

• 2.1 Key Market Highlights by Type
• 2.2 Key Market Highlights by Product
• 2.3 Key Market Highlights by Services
• 2.4 Key Market Highlights by Technology
• 2.5 Key Market Highlights by Application
• 2.6 Key Market Highlights by End User
• 2.7 Key Market Highlights by Device
• 2.8 Key Market Highlights by Process
• 2.9 Key Market Highlights by Solutions

3 Market Dynamics

• 3.1 Macroeconomic Analysis
• 3.2 Market Trends
• 3.3 Market Drivers
• 3.4 Market Opportunities
• 3.5 Market Restraints
• 3.6 CAGR Growth Analysis
• 3.7 Impact Analysis
• 3.8 Emerging Markets
• 3.9 Technology Roadmap
• 3.10 Strategic Frameworks
  • 3.10.1 PORTER's 5 Forces Model
  • 3.10.2 ANSOFF Matrix
  • 3.10.3 4P's Model
  • 3.10.4 PESTEL Analysis

4 Segment Analysis

• 4.1 Market Size & Forecast by Type (2020-2035)
  • 4.1.1 Cognitive Enhancement
  • 4.1.2 Rehabilitation
  • 4.1.3 Learning and Memory
  • 4.1.4 Stress Reduction
  • 4.1.5 Mood Regulation
• 4.2 Market Size & Forecast by Product (2020-2035)
  • 4.2.1 Neurostimulation Devices
  • 4.2.2 Cognitive Training Software
  • 4.2.3 Neurofeedback Systems
  • 4.2.4 Brain Monitoring Devices
• 4.3 Market Size & Forecast by Services (2020-2035)
  • 4.3.1 Consultancy Services
  • 4.3.2 Training and Workshops
  • 4.3.3 Therapeutic Services
  • 4.3.4 Research and Development
• 4.4 Market Size & Forecast by Technology (2020-2035)
  • 4.4.1 Transcranial Magnetic Stimulation
  • 4.4.2 Electroencephalography
  • 4.4.3 Functional Magnetic Resonance Imaging
  • 4.4.4 Near-Infrared Spectroscopy
• 4.5 Market Size & Forecast by Application (2020-2035)
  • 4.5.1 Healthcare and Wellness
  • 4.5.2 Education and Learning
  • 4.5.3 Sports and Performance
  • 4.5.4 Military and Defense
  • 4.5.5 Entertainment and Gaming
• 4.6 Market Size & Forecast by End User (2020-2035)
  • 4.6.1 Hospitals and Clinics
  • 4.6.2 Academic and Research Institutes
  • 4.6.3 Corporate Enterprises
  • 4.6.4 Sports Organizations
  • 4.6.5 Military and Defense Agencies
• 4.7 Market Size & Forecast by Device (2020-2035)
  • 4.7.1 Wearable Devices
  • 4.7.2 Non-Invasive Devices
  • 4.7.3 Invasive Devices
  • 4.7.4 Portable Devices
  • 4.7.5 Stationary Devices
• 4.8 Market Size & Forecast by Process (2020-2035)
  • 4.8.1 Neurofeedback
  • 4.8.2 Brain Stimulation
  • 4.8.3 Cognitive Training
  • 4.8.4 Mindfulness and Meditation
• 4.9 Market Size & Forecast by Solutions (2020-2035)
  • 4.9.1 Personalized Training Solutions
  • 4.9.2 Integrated Therapy Solutions
  • 4.9.3 AI-Based Solutions
  • 4.9.4 Cloud-Based Solutions

5 Regional Analysis

• 5.1 Global Market Overview
• 5.2 North America Market Size (2020-2035)
  • 5.2.1 United States
    • 5.2.1.1 Type
    • 5.2.1.2 Product
    • 5.2.1.3 Services
    • 5.2.1.4 Technology
    • 5.2.1.5 Application
    • 5.2.1.6 End User
    • 5.2.1.7 Device
    • 5.2.1.8 Process
    • 5.2.1.9 Solutions
  • 5.2.2 Canada
    • 5.2.2.1 Type
    • 5.2.2.2 Product
    • 5.2.2.3 Services
    • 5.2.2.4 Technology
    • 5.2.2.5 Application
    • 5.2.2.6 End User
    • 5.2.2.7 Device
    • 5.2.2.8 Process
    • 5.2.2.9 Solutions
  • 5.2.3 Mexico
    • 5.2.3.1 Type
    • 5.2.3.2 Product
    • 5.2.3.3 Services
    • 5.2.3.4 Technology
    • 5.2.3.5 Application
    • 5.2.3.6 End User
    • 5.2.3.7 Device
    • 5.2.3.8 Process
    • 5.2.3.9 Solutions
• 5.3 Latin America Market Size (2020-2035)
  • 5.3.1 Brazil
    • 5.3.1.1 Type
    • 5.3.1.2 Product
    • 5.3.1.3 Services
    • 5.3.1.4 Technology
    • 5.3.1.5 Application
    • 5.3.1.6 End User
    • 5.3.1.7 Device
    • 5.3.1.8 Process
    • 5.3.1.9 Solutions
  • 5.3.2 Argentina
    • 5.3.2.1 Type
    • 5.3.2.2 Product
    • 5.3.2.3 Services
    • 5.3.2.4 Technology
    • 5.3.2.5 Application
    • 5.3.2.6 End User
    • 5.3.2.7 Device
    • 5.3.2.8 Process
    • 5.3.2.9 Solutions
  • 5.3.3 Rest of Latin America
    • 5.3.3.1 Type
    • 5.3.3.2 Product
    • 5.3.3.3 Services
    • 5.3.3.4 Technology
    • 5.3.3.5 Application
    • 5.3.3.6 End User
    • 5.3.3.7 Device
    • 5.3.3.8 Process
    • 5.3.3.9 Solutions
• 5.4 Asia-Pacific Market Size (2020-2035)
  • 5.4.1 China
    • 5.4.1.1 Type
    • 5.4.1.2 Product
    • 5.4.1.3 Services
    • 5.4.1.4 Technology
    • 5.4.1.5 Application
    • 5.4.1.6 End User
    • 5.4.1.7 Device
    • 5.4.1.8 Process
    • 5.4.1.9 Solutions
  • 5.4.2 India
    • 5.4.2.1 Type
    • 5.4.2.2 Product
    • 5.4.2.3 Services
    • 5.4.2.4 Technology
    • 5.4.2.5 Application
    • 5.4.2.6 End User
    • 5.4.2.7 Device
    • 5.4.2.8 Process
    • 5.4.2.9 Solutions
  • 5.4.3 South Korea
    • 5.4.3.1 Type
    • 5.4.3.2 Product
    • 5.4.3.3 Services
    • 5.4.3.4 Technology
    • 5.4.3.5 Application
    • 5.4.3.6 End User
    • 5.4.3.7 Device
    • 5.4.3.8 Process
    • 5.4.3.9 Solutions
  • 5.4.4 Japan
    • 5.4.4.1 Type
    • 5.4.4.2 Product
    • 5.4.4.3 Services
    • 5.4.4.4 Technology
    • 5.4.4.5 Application
    • 5.4.4.6 End User
    • 5.4.4.7 Device
    • 5.4.4.8 Process
    • 5.4.4.9 Solutions
  • 5.4.5 Australia
    • 5.4.5.1 Type
    • 5.4.5.2 Product
    • 5.4.5.3 Services
    • 5.4.5.4 Technology
    • 5.4.5.5 Application
    • 5.4.5.6 End User
    • 5.4.5.7 Device
    • 5.4.5.8 Process
    • 5.4.5.9 Solutions
  • 5.4.6 Taiwan
    • 5.4.6.1 Type
    • 5.4.6.2 Product
    • 5.4.6.3 Services
    • 5.4.6.4 Technology
    • 5.4.6.5 Application
    • 5.4.6.6 End User
    • 5.4.6.7 Device
    • 5.4.6.8 Process
    • 5.4.6.9 Solutions
  • 5.4.7 Rest of APAC
    • 5.4.7.1 Type
    • 5.4.7.2 Product
    • 5.4.7.3 Services
    • 5.4.7.4 Technology
    • 5.4.7.5 Application
    • 5.4.7.6 End User
    • 5.4.7.7 Device
    • 5.4.7.8 Process
    • 5.4.7.9 Solutions
• 5.5 Europe Market Size (2020-2035)
  • 5.5.1 Germany
    • 5.5.1.1 Type
    • 5.5.1.2 Product
    • 5.5.1.3 Services
    • 5.5.1.4 Technology
    • 5.5.1.5 Application
    • 5.5.1.6 End User
    • 5.5.1.7 Device
    • 5.5.1.8 Process
    • 5.5.1.9 Solutions
  • 5.5.2 France
    • 5.5.2.1 Type
    • 5.5.2.2 Product
    • 5.5.2.3 Services
    • 5.5.2.4 Technology
    • 5.5.2.5 Application
    • 5.5.2.6 End User
    • 5.5.2.7 Device
    • 5.5.2.8 Process
    • 5.5.2.9 Solutions
  • 5.5.3 United Kingdom
    • 5.5.3.1 Type
    • 5.5.3.2 Product
    • 5.5.3.3 Services
    • 5.5.3.4 Technology
    • 5.5.3.5 Application
    • 5.5.3.6 End User
    • 5.5.3.7 Device
    • 5.5.3.8 Process
    • 5.5.3.9 Solutions
  • 5.5.4 Spain
    • 5.5.4.1 Type
    • 5.5.4.2 Product
    • 5.5.4.3 Services
    • 5.5.4.4 Technology
    • 5.5.4.5 Application
    • 5.5.4.6 End User
    • 5.5.4.7 Device
    • 5.5.4.8 Process
    • 5.5.4.9 Solutions
  • 5.5.5 Italy
    • 5.5.5.1 Type
    • 5.5.5.2 Product
    • 5.5.5.3 Services
    • 5.5.5.4 Technology
    • 5.5.5.5 Application
    • 5.5.5.6 End User
    • 5.5.5.7 Device
    • 5.5.5.8 Process
    • 5.5.5.9 Solutions
  • 5.5.6 Rest of Europe
    • 5.5.6.1 Type
    • 5.5.6.2 Product
    • 5.5.6.3 Services
    • 5.5.6.4 Technology
    • 5.5.6.5 Application
    • 5.5.6.6 End User
    • 5.5.6.7 Device
    • 5.5.6.8 Process
    • 5.5.6.9 Solutions
• 5.6 Middle East & Africa Market Size (2020-2035)
  • 5.6.1 Saudi Arabia
    • 5.6.1.1 Type
    • 5.6.1.2 Product
    • 5.6.1.3 Services
    • 5.6.1.4 Technology
    • 5.6.1.5 Application
    • 5.6.1.6 End User
    • 5.6.1.7 Device
    • 5.6.1.8 Process
    • 5.6.1.9 Solutions
  • 5.6.2 United Arab Emirates
    • 5.6.2.1 Type
    • 5.6.2.2 Product
    • 5.6.2.3 Services
    • 5.6.2.4 Technology
    • 5.6.2.5 Application
    • 5.6.2.6 End User
    • 5.6.2.7 Device
    • 5.6.2.8 Process
    • 5.6.2.9 Solutions
  • 5.6.3 South Africa
    • 5.6.3.1 Type
    • 5.6.3.2 Product
    • 5.6.3.3 Services
    • 5.6.3.4 Technology
    • 5.6.3.5 Application
    • 5.6.3.6 End User
    • 5.6.3.7 Device
    • 5.6.3.8 Process
    • 5.6.3.9 Solutions
  • 5.6.4 Sub-Saharan Africa
    • 5.6.4.1 Type
    • 5.6.4.2 Product
    • 5.6.4.3 Services
    • 5.6.4.4 Technology
    • 5.6.4.5 Application
    • 5.6.4.6 End User
    • 5.6.4.7 Device
    • 5.6.4.8 Process
    • 5.6.4.9 Solutions
  • 5.6.5 Rest of MEA
    • 5.6.5.1 Type
    • 5.6.5.2 Product
    • 5.6.5.3 Services
    • 5.6.5.4 Technology
    • 5.6.5.5 Application
    • 5.6.5.6 End User
    • 5.6.5.7 Device
    • 5.6.5.8 Process
    • 5.6.5.9 Solutions

6 Market Strategy

• 6.1 Demand-Supply Gap Analysis
• 6.2 Trade & Logistics Constraints
• 6.3 Price-Cost-Margin Trends
• 6.4 Market Penetration
• 6.5 Consumer Analysis
• 6.6 Regulatory Snapshot

7 Competitive Intelligence

• 7.1 Market Positioning
• 7.2 Market Share
• 7.3 Competition Benchmarking
• 7.4 Top Company Strategies

8 Company Profiles

• 8.1 Neuro Flow
  • 8.1.1 Overview
  • 8.1.2 Product Summary
  • 8.1.3 Financial Performance
  • 8.1.4 SWOT Analysis
• 8.2 Cognifit
  • 8.2.1 Overview
  • 8.2.2 Product Summary
  • 8.2.3 Financial Performance
  • 8.2.4 SWOT Analysis
• 8.3 Brain HQ
  • 8.3.1 Overview
  • 8.3.2 Product Summary
  • 8.3.3 Financial Performance
  • 8.3.4 SWOT Analysis
• 8.4 Neuro Nation
  • 8.4.1 Overview
  • 8.4.2 Product Summary
  • 8.4.3 Financial Performance
  • 8.4.4 SWOT Analysis
• 8.5 Lumosity
  • 8.5.1 Overview
  • 8.5.2 Product Summary
  • 8.5.3 Financial Performance
  • 8.5.4 SWOT Analysis
• 8.6 Elevate
  • 8.6.1 Overview
  • 8.6.2 Product Summary
  • 8.6.3 Financial Performance
  • 8.6.4 SWOT Analysis
• 8.7 Posit Science
  • 8.7.1 Overview
  • 8.7.2 Product Summary
  • 8.7.3 Financial Performance
  • 8.7.4 SWOT Analysis
• 8.8 Mind Maze
  • 8.8.1 Overview
  • 8.8.2 Product Summary
  • 8.8.3 Financial Performance
  • 8.8.4 SWOT Analysis
• 8.9 Brain Co
  • 8.9.1 Overview
  • 8.9.2 Product Summary
  • 8.9.3 Financial Performance
  • 8.9.4 SWOT Analysis
• 8.10 Neurable
  • 8.10.1 Overview
  • 8.10.2 Product Summary
  • 8.10.3 Financial Performance
  • 8.10.4 SWOT Analysis
• 8.11 Neuro Sky
  • 8.11.1 Overview
  • 8.11.2 Product Summary
  • 8.11.3 Financial Performance
  • 8.11.4 SWOT Analysis
• 8.12 Emotiv
  • 8.12.1 Overview
  • 8.12.2 Product Summary
  • 8.12.3 Financial Performance
  • 8.12.4 SWOT Analysis
• 8.13 Muse
  • 8.13.1 Overview
  • 8.13.2 Product Summary
  • 8.13.3 Financial Performance
  • 8.13.4 SWOT Analysis
• 8.14 Insight Timer
  • 8.14.1 Overview
  • 8.14.2 Product Summary
  • 8.14.3 Financial Performance
  • 8.14.4 SWOT Analysis
• 8.15 Brain.fm
  • 8.15.1 Overview
  • 8.15.2 Product Summary
  • 8.15.3 Financial Performance
  • 8.15.4 SWOT Analysis
• 8.16 Focus@ Will
  • 8.16.1 Overview
  • 8.16.2 Product Summary
  • 8.16.3 Financial Performance
  • 8.16.4 SWOT Analysis
• 8.17 Happify
  • 8.17.1 Overview
  • 8.17.2 Product Summary
  • 8.17.3 Financial Performance
  • 8.17.4 SWOT Analysis
• 8.18 Headspace Health
  • 8.18.1 Overview
  • 8.18.2 Product Summary
  • 8.18.3 Financial Performance
  • 8.18.4 SWOT Analysis
• 8.19 Calm
  • 8.19.1 Overview
  • 8.19.2 Product Summary
  • 8.19.3 Financial Performance
  • 8.19.4 SWOT Analysis
• 8.20 Synctuition
  • 8.20.1 Overview
  • 8.20.2 Product Summary
  • 8.20.3 Financial Performance
  • 8.20.4 SWOT Analysis

9 About Us

• 9.1 About Us
• 9.2 Research Methodology
• 9.3 Research Workflow
• 9.4 Consulting Services
• 9.5 Our Clients
• 9.6 Client Testimonials
• 9.7 Contact Us